学术探索
学术期刊
新闻热点
数据分析
智能评审

RISK OF SECONDARY LEUKEMIA FOLLOWING HIGH CUMULATIVE DOSES OF ETOPOSIDE DURING CHEMOTHERAPY FOR TESTICULAR CANCER

被引：39
作者：
BOKEMEYER, C
SCHMOLL, HJ
KUCZYK, MA
BEYER, J
SIEGERT, W
机构：
[1] UNIV HANNOVER,SCH MED,DEPT UROL,D-30623 HANNOVER,GERMANY
[2] UNIV BERLIN,CLIN RUDOLF VIRCHOW,DEPT HEMATOL & ONCOL,BERLIN,GERMANY
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1995年 / 87卷 / 01期
关键词：
D O I：
10.1093/jnci/87.1.58
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：58 / 60
页数：3
相关论文
共 13 条
  • [1] ACUTE NONLYMPHOCYTIC LEUKEMIA IN GERM-CELL TUMOR PATIENTS TREATED WITH ETOPOSIDE-CONTAINING CHEMOTHERAPY
    BAJORIN, DF
    MOTZER, RJ
    RODRIGUEZ, E
    MURPHY, B
    BOSL, GJ
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (01) : 60 - 62
  • [2] A PHASE I/II STUDY OF A STEPWISE DOSE-ESCALATED REGIMEN OF CISPLATIN, ETOPOSIDE AND IFOSFAMIDE PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN PATIENTS WITH ADVANCED GERM-CELL TUMORS
    BOKEMEYER, C
    SCHMOLL, HJ
    HARSTRICK, A
    ILLIGER, HJ
    METZNER, B
    RATH, U
    HOHNLOSER, J
    CLEMM, C
    BERDEL, W
    SIEGERT, W
    RUTHER, U
    OSTERMANN, H
    KNEBA, M
    HARTLAPP, JH
    SCHRODER, M
    POLIWODA, H
    [J]. EUROPEAN JOURNAL OF CANCER, 1993, 29A (16) : 2225 - 2231
  • [3] SECONDARY NEOPLASMS FOLLOWING TREATMENT OF MALIGNANT GERM-CELL TUMORS
    BOKEMEYER, C
    SCHMOLL, HJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (09) : 1703 - 1709
  • [4] BOSHOFF CH, 1994, P AN M AM SOC CLIN, V13, P245
  • [5] MUIR C, 1987, CANCER INCIDENCE 5 C, V5, P504
  • [6] SECONDARY LEUKEMIA ASSOCIATED WITH A CONVENTIONAL DOSE OF ETOPOSIDE - REVIEW OF SERIAL GERM-CELL TUMOR PROTOCOLS
    NICHOLS, CR
    BREEDEN, ES
    LOEHRER, PJ
    WILLIAMS, SD
    EINHORN, LH
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (01) : 36 - 40
  • [7] PEDERSENBJERGAA.J, 1991, LANCET, V338, P359
  • [8] PEDERSENBJERGAA.J, 1992, J CLIN ONCOL, V10, P1444
  • [9] SECONDARY ACUTE MYELOID-LEUKEMIA IN CHILDREN PREVIOUSLY TREATED WITH ALKYLATING-AGENTS, INTERCALATING TOPOISOMERASE-II INHIBITORS, AND IRRADIATION
    SANDOVAL, C
    PUI, CH
    BOWMAN, LC
    HEATON, D
    HURWITZ, CA
    RAIMONDI, SC
    BEHM, FG
    HEAD, DR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (06) : 1039 - 1045
  • [10] DISSEMINATED TESTICULAR CANCER WITH BULKY DISEASE - RESULTS OF A PHASE-II STUDY WITH CISPLATIN ULTRA HIGH-DOSE VP-16 BLEOMYCIN
    SCHMOLL, HJ
    SCHUBERT, I
    ARNOLD, H
    DOLKEN, G
    HECHT, T
    BERGMANN, L
    ILLIGER, J
    FINK, U
    PREISS, J
    PFREUNDSCHUH, M
    KAULEN, H
    BONFERT, B
    HO, AD
    MANEGOLD, C
    MAYR, A
    HOFFMANN, L
    WEISS, J
    HECKER, H
    [J]. INTERNATIONAL JOURNAL OF ANDROLOGY, 1987, 10 (01): : 311 - 317
12